Evidence map›Paper›PMID 29276386›Full record

ArticleInternational journal of nanomedicine2017

Guided bone regeneration with asymmetric collagen-chitosan membranes containing aspirin-loaded chitosan nanoparticles.

Jiayu Zhang, Shiqing Ma, Zihao Liu, Hongjuan Geng, Xin Lu, Xi Zhang, Hongjie Li, Chenyuan Gao, Xu Zhang, Ping Gao

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 46 citations in OpenAlex.

  1. Natural Polymers in Guided Bone Regeneration (GBR).Journal of functional biomaterials · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Advances in Barrier Membranes for Guided Bone Regeneration Techniques.Frontiers in bioengineering and biotechnology · 2022
    Review
  12. Article
  13. A Rapid and Convenient Approach to Construct Porous Collagen MembranesFrontiers in bioengineering and biotechnology · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jiayu ZhangSchool of Dentistry, Hospital of Stomatology, Tianjin Medical University, Tianjin.
Shiqing MaSchool of Dentistry, Hospital of Stomatology, Tianjin Medical University, Tianjin.
Zihao LiuSchool of Dentistry, Hospital of Stomatology, Tianjin Medical University, Tianjin.
Hongjuan GengSchool of Dentistry, Hospital of Stomatology, Tianjin Medical University, Tianjin.
Xin LuSchool of Dentistry, Hospital of Stomatology, Tianjin Medical University, Tianjin.
Xi ZhangSchool of Dentistry, Hospital of Stomatology, Tianjin Medical University, Tianjin.
Hongjie LiSchool of Dentistry, Hospital of Stomatology, Tianjin Medical University, Tianjin.
Chenyuan GaoBeijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing, People's Republic of China.
Xu ZhangSchool of Dentistry, Hospital of Stomatology, Tianjin Medical University, Tianjin.
Ping GaoSchool of Dentistry, Hospital of Stomatology, Tianjin Medical University, Tianjin.
Tianjin Medical University · CNBeijing University of Chemical Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMembranes allowing the sustained release of drugs that can achieve cell adhesion are very promising for guided bone regeneration. Previous studies have suggested that aspirin has the potential to promote bone regeneration. The purpose of this study was to prepare a local drug delivery system with aspirin-loaded chitosan nanoparticles (ACS) contained in an asymmetric collagen-chitosan membrane (CCM).

methodsIn this study, the ACS were fabricated using different concentrations of aspirin (5 mg, 25 mg, 50 mg, and 75 mg). The drug release behavior of ACS was studied. Transmission electron microscopy (TEM) and scanning electron microscopy (SEM) were used to examine the micromorphology of ACS and aspirin-loaded chitosan nanoparticles contained in chitosan-collagen membranes (ACS-CCM). In vitro bone mesenchymal stem cells (BMSCs) were cultured and critical-sized cranial defects on Sprague-Dawley rats were made to evaluate the effect of the ACS-CCM on bone regeneration.

resultsDrug release behavior results of ACS showed that the nanoparticles fabricated in this study could successfully sustain the release of the drug. TEM showed the morphology of the nanoparticles. SEM images indicated that the asymmetric membrane comprised a loose collagen layer and a dense chitosan layer. In vitro studies showed that ACS-CCM could promote the proliferation of BMSCs, and that the degree of differentiated BMSCs seeded on CCMs containing 50 mg of ACS was higher than that of other membranes. Micro-computed tomography showed that 50 mg of ACS-CCM resulted in enhanced bone regeneration compared with the control group.

conclusionThis study shows that the ACS-CCM would allow the sustained release of aspirin and have further osteogenic potential. This membrane is a promising therapeutic approach to guiding bone regeneration.

Indexed as

Bone RegenerationAnimalsAspirinChitosanCollagenDrug Delivery SystemsDrug LiberationMaterials TestingMembranes, ArtificialMesenchymal Stem CellsMicroscopy, Electron, ScanningMicroscopy, Electron, TransmissionNanoparticlesOsteogenesisRats, Sprague-DawleyX-Ray MicrotomographyAspirinChitosanCollagenMembranes, Artificialaspirindrug releaseguided bone regenerationmembranenanoparticle

Identifiers

PMID29276386
PMCPMC5733920
OpenAlexW2774432532

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.